This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Evidence-Based Medicine  • Neurology  • Cerebrovascular Disease  • Review  • Stroke  • Alert me on articles by topic

A Meta-analysis

Homocysteine Studies Collaboration

JAMA. 2002;288:2015-2022.

Context  It has been suggested that total blood homocysteine concentrations are associated with the risk of ischemic heart disease (IHD) and stroke.

Objective  To assess the relationship of homocysteine concentrations with vascular disease risk.

Data Sources  MEDLINE was searched for articles published from January 1966 to January 1999. Relevant studies were identified by systematic searches of the literature for all reported observational studies of associations between IHD or stroke risk and homocysteine concentrations. Additional studies were identified by a hand search of references of original articles or review articles and by personal communication with relevant investigators.

Study Selection  Studies were included if they had data available by January 1999 on total blood homocysteine concentrations, sex, and age at event. Studies were excluded if they measured only blood concentrations of free homocysteine or of homocysteine after a methionine-loading test or if relevant clinical data were unavailable or incomplete.

Data Extraction  Data from 30 prospective or retrospective studies involving a total of 5073 IHD events and 1113 stroke events were included in a meta-analysis of individual participant data, with allowance made for differences between studies, for confounding by known cardiovascular risk factors, and for regression dilution bias. Combined odds ratios (ORs) for the association of IHD and stroke with blood homocysteine concentrations were obtained by using conditional logistic regression.

Data Synthesis  Stronger associations were observed in retrospective studies of homocysteine measured in blood collected after the onset of disease than in prospective studies among individuals who had no history of cardiovascular disease when blood was collected. After adjustment for known cardiovascular risk factors and regression dilution bias in the prospective studies, a 25% lower usual (corrected for regression dilution bias) homocysteine level (about 3 µmol/L [0.41 mg/L]) was associated with an 11% (OR, 0.89; 95% confidence interval [CI], 0.83-0.96) lower IHD risk and 19% (OR, 0.81; 95% CI, 0.69-0.95) lower stroke risk.

Conclusions  This meta-analysis of observational studies suggests that elevated homocysteine is at most a modest independent predictor of IHD and stroke risk in healthy populations. Studies of the impact on disease risk of genetic variants that affect blood homocysteine concentrations will help determine whether homocysteine is causally related to vascular disease, as may large randomized trials of the effects on IHD and stroke of vitamin supplementation to lower blood homocysteine concentrations.

Author Members of the Homocysteine Studies Collaboration: R. Clarke, MD, R. Collins, MB, S. Lewington, DPhil, A. Donald, PhD; G. Alfthan, MD, J. Tuomilehto, MD; E. Arnesen, MD, K. Bonaa, MD; J. Blacher, MD; G. H. J. Boers, MD; A. Bostom, MD; M. L. Bots, MD, D. E. Grobbee, MD; L. Brattström, MD; M. M. B. Breteler, MD, A. Hofman, MD; J. C. Chambers, MRCP, J. S. Kooner, FRCP; B. M. Coull, MD; R. W. Evans, PhD, L. H. Kuller; S. Evers, MD; A. R. Folsom, MD; G. Freyburger, MD, F. Parrot, MD; J. Genest Jr, MD, K. Dalery, MD; I. M. Graham, MD, L. Daly, PhD; E. K. Hoogeveen, MD, P. J. Kostense, PhD, C. D. A. Stehouwer, MD; P. N. Hopkins, MD; P. Jacques, ScD, J. Selhub, PhD; F. C. Luft, MD; P. Jungers, MD; A. Lindgren, MD; Y. I. Lolin, MD; F. Loehrer, MD, B. Fowler, PhD; M. A. Mansoor, MD; M. R. Malinow, MD, P. Ducimetiere, MD; O. Nygard, MD, H. Refsum, MD, S. E. Vollset, MD, P. M. Ueland, MD; G. S. Omenn, MD, S. A. A. Beresford, PhD; J. M. Roseman, MD; H. H. Parving, MD, M. A. Gall, MD; I. J. Perry, MD, S. B. Ebrahim, MD, A. G. Shaper, MD; K. Robinson, MD, D. W. Jacobsen, PhD; S. M. Schwartz, PhD; D. S. Siscovick, MD; M. J. Stampfer, MD, C. H. Hennekens, MD; E. J. M. Feskens, D. Kromhout, PhD; J. Ubbink, MD, P. Elwood, MD, J. Pickering, MSc; P. Verhoef, PhD; A. von Eckardstein, MD, H. Schulte, PhD, G. Assmann, MD; N. Wald, FRCP, M. R. Law, FRCP; P. H. Whincup, FRCP; D. E. L. Wilcken, MD; P. Sherliker, BSc; P. Linksted, MSc; and G. Davey Smith.

RELATED ARTICLES

MTHFR 677CT Polymorphism and Risk of Coronary Heart Disease: A Meta-analysis
Mariska Klerk, Petra Verhoef, Robert Clarke, Henk J. Blom, Frans J. Kok, Evert G. Schouten, and and the MTHFR Studies Collaboration Group
JAMA. 2002;288(16):2023-2031.
ABSTRACT | FULL TEXT  

Homocysteine and Coronary Heart Disease: How Great Is the Hazard?
Peter W. F. Wilson
JAMA. 2002;288(16):2042-2043.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Murine Models of Hyperhomocysteinemia and Their Vascular Phenotypes
Dayal and Lentz
Arterioscler. Thromb. Vasc. Bio. 2008;28:1596-1605.
ABSTRACT | FULL TEXT  

Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia
Dayal et al.
Am. J. Physiol. Heart Circ. Physiol. 2008;295:H816-H825.
ABSTRACT | FULL TEXT  

Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bank
Yang et al.
Am. J. Clin. Nutr. 2008;88:232-246.
ABSTRACT | FULL TEXT  

Mesna for Treatment of Hyperhomocysteinemia in Hemodialysis Patients: A Placebo-Controlled, Double-Blind, Randomized Trial
Urquhart et al.
CJASN 2008;3:1041-1047.
ABSTRACT | FULL TEXT  

The Homocysteine Paradox
Rodionov and Lentz
Arterioscler. Thromb. Vasc. Bio. 2008;28:1031-1033.
FULL TEXT  

Plasma Homocysteine, but Not Folate or Vitamin B-12, Predicts Mortality in Older People in the United Kingdom
Dangour et al.
J. Nutr. 2008;138:1121-1128.
ABSTRACT | FULL TEXT  

Effect of Folic Acid and B Vitamins on Risk of Cardiovascular Events and Total Mortality Among Women at High Risk for Cardiovascular Disease: A Randomized Trial
Albert et al.
JAMA 2008;299:2027-2036.
ABSTRACT | FULL TEXT  

Homocysteine-Lowering B Vitamin Therapy in Cardiovascular Prevention--Wrong Again?
Lonn
JAMA 2008;299:2086-2087.
FULL TEXT  

Did national folic acid fortification reduce socioeconomic and racial disparities in folate status in the US?
Dowd and Aiello
Int J Epidemiol 2008;0:dyn066v1-dyn066.
ABSTRACT | FULL TEXT  

Trends in Circulating Concentrations of Total Homocysteine among US Adolescents and Adults: Findings from the 1991-1994 and 1999-2004 National Health and Nutrition Examination Surveys
Pfeiffer et al.
Clin. Chem. 2008;54:801-813.
ABSTRACT | FULL TEXT  

Mechanisms and potential therapeutic targets for folic acid in cardiovascular disease
Moens et al.
Am. J. Physiol. Heart Circ. Physiol. 2008;294:H1971-H1977.
ABSTRACT | FULL TEXT  

Homocysteine Inhibits Arterial Endothelial Cell Growth Through Transcriptional Downregulation of Fibroblast Growth Factor-2 Involving G Protein and DNA Methylation
Chang et al.
Circ. Res. 2008;102:933-941.
ABSTRACT | FULL TEXT  

Folate, Vitamin B6, Vitamin B12, and Methionine Intakes and Risk of Stroke Subtypes in Male Smokers
Larsson et al.
Am J Epidemiol 2008;167:954-961.
ABSTRACT | FULL TEXT  

How Does Folic Acid Cure Heart Attacks?
Tian and Ingwall
Circulation 2008;117:1772-1774.
FULL TEXT  

Predictive value of folate, vitamin B12 and homocysteine levels in late-life depression
Kim et al.
Br. J. Psychiatry 2008;192:268-274.
ABSTRACT | FULL TEXT  

Folic Acid and Multivitamin Supplement Use and Risk of Placental Abruption: A Population-based Registry Study
Nilsen et al.
Am J Epidemiol 2008;167:867-874.
ABSTRACT | FULL TEXT  

Dietary and supplementary betaine: acute effects on plasma betaine and homocysteine concentrations under standard and postmethionine load conditions in healthy male subjects
Atkinson et al.
Am. J. Clin. Nutr. 2008;87:577-585.
ABSTRACT | FULL TEXT  

Lowering Plasma Homocysteine Concentrations of Older Men and Women with Folate, Vitamin B-12, and Vitamin B-6 Does Not Affect the Proportion of (n-3) Long Chain Polyunsaturated Fatty Acids in Plasma Phosphatidylcholine
Crowe et al.
J. Nutr. 2008;138:551-555.
ABSTRACT | FULL TEXT  

Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study
Mann et al.
Nephrol Dial Transplant 2008;23:645-653.
ABSTRACT | FULL TEXT  

Homocysteine Induces Monocyte Chemoattractant Protein-1 Expression in Hepatocytes Mediated via Activator Protein-1 Activation
Woo et al.
J. Biol. Chem. 2008;283:1282-1292.
ABSTRACT | FULL TEXT  

Cardiovascular Risk Factors and Venous Thromboembolism: A Meta-Analysis
Ageno et al.
Circulation 2008;117:93-102.
ABSTRACT | FULL TEXT  

Hypermethylation of Fads2 and Altered Hepatic Fatty Acid and Phospholipid Metabolism in Mice with Hyperhomocysteinemia
Devlin et al.
J. Biol. Chem. 2007;282:37082-37090.
ABSTRACT | FULL TEXT  

S-Adenosylhomocysteine a better indicator of vascular disease than homocysteine?
Wagner and Koury
Am. J. Clin. Nutr. 2007;86:1581-1585.
ABSTRACT | FULL TEXT  

The risk of venous and arterial thrombosis in hyperhomocysteinemic subjects may be a result of elevated factor VIII levels
Lijfering et al.
haematol 2007;92:1703-1706.
ABSTRACT | FULL TEXT  

Coronary artery disease risk factors in patients with schizophrenia: effects of short term antipsychotic treatment
Sarandol et al.
J Psychopharmacol 2007;21:857-863.
ABSTRACT  

B Vitamin Plasma Levels and the Risk of Ischemic Stroke and Transient Ischemic Attack in a German Cohort
Weikert et al.
Stroke 2007;38:2912-2918.
ABSTRACT | FULL TEXT  

The association between betaine and choline intakes and the plasma concentrations of homocysteine in women
Chiuve et al.
Am. J. Clin. Nutr. 2007;86:1073-1081.
ABSTRACT | FULL TEXT  

Association of blood lead and homocysteine levels among lead exposed subjects in Vietnam and Singapore
Chia et al.
Occup. Environ. Med. 2007;64:688-693.
ABSTRACT | FULL TEXT  

Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial
Ferreira et al.
Rheumatology (Oxford) 2007;46:1560-1565.
ABSTRACT | FULL TEXT  

Effect of Homocysteine Lowering on Mortality and Vascular Disease in Advanced Chronic Kidney Disease and End-stage Renal Disease: A Randomized Controlled Trial
Jamison et al.
JAMA 2007;298:1163-1170.
ABSTRACT | FULL TEXT  

B Vitamins for the Prevention of Vascular Disease: Insufficient Evidence to Justify Treatment
Baigent and Clarke
JAMA 2007;298:1212-1214.
FULL TEXT  

Folic acid improves vascular reactivity in humans: a meta-analysis of randomized controlled trials
de Bree et al.
Am. J. Clin. Nutr. 2007;86:610-617.
ABSTRACT | FULL TEXT  

Endogenous Sex Hormones as Risk Factors for Dementia in Elderly Men and Women
Ravaglia et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2007;62:1035-1041.
ABSTRACT | FULL TEXT  

The heritability of plasma homocysteine, and the influence of genetic variation in the homocysteine methylation pathway
Siva et al.
QJM 2007;100:495-499.
ABSTRACT | FULL TEXT  

High frequency of vitamin B12 deficiency in asymptomatic individuals homozygous to MTHFR C677T mutation is associated with endothelial dysfunction and homocysteinemia
Zittan et al.
Am. J. Physiol. Heart Circ. Physiol. 2007;293:H860-H865.
ABSTRACT | FULL TEXT  

Homocysteine and Cardiovascular Risk: Considering the Evidence in the Context of Study Design, Folate Fortification, and Statistical Power
Ueland and Clarke
Clin. Chem. 2007;53:807-809.
FULL TEXT  

Lowering Homocysteine with B Vitamins Has No Effect on Blood Pressure in Older Adults
McMahon et al.
J. Nutr. 2007;137:1183-1187.
ABSTRACT | FULL TEXT  

Homocysteine, 5,10-Methylenetetrahydrofolate Reductase 677C>T Polymorphism, Nutrient Intake, and Incident Cardiovascular Disease in 24 968 Initially Healthy Women
Zee et al.
Clin. Chem. 2007;53:845-851.
ABSTRACT | FULL TEXT  

Folic Acid Supplementation and Cardiovascular Diseases
Dentali et al.
JAMA 2007;297:1549-1550.
FULL TEXT  

A comprehensive view of sex-specific issues related to cardiovascular disease
Pilote et al.
CMAJ 2007;176:S1-S44.
ABSTRACT | FULL TEXT  

Both vitamin B6 and total homocysteine plasma levels predict long-term atherothrombotic events in healthy subjects
Vanuzzo et al.
Eur Heart J 2007;28:484-491.
ABSTRACT | FULL TEXT  

Homocysteine, B vitamins, and the risk of dementia
Clarke
Am. J. Clin. Nutr. 2007;85:329-330.
FULL TEXT  

Lowering homocysteine with B vitamins has no effect on biomarkers of bone turnover in older persons: a 2-y randomized controlled trial
Green et al.
Am. J. Clin. Nutr. 2007;85:460-464.
ABSTRACT | FULL TEXT  

Cardiovascular Fitness Is Negatively Associated With Homocysteine Levels in Female Adolescents
Ruiz et al.
Arch Pediatr Adolesc Med 2007;161:166-171.
ABSTRACT | FULL TEXT  

Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome
Hajer et al.
Heart 2007;93:216-220.
ABSTRACT | FULL TEXT  

Elevated Homocysteine Is Associated With Reduced Regional Left Ventricular Function: The Multi-Ethnic Study of Atherosclerosis
Nasir et al.
Circulation 2007;115:180-187.
ABSTRACT | FULL TEXT  

The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation
Suliman et al.
Nephrol Dial Transplant 2007;22:209-217.
ABSTRACT | FULL TEXT  

Prothrombotic Effects of Hyperhomocysteinemia and Hypercholesterolemia in ApoE-Deficient Mice
Wilson et al.
Arterioscler. Thromb. Vasc. Bio. 2007;27:233-240.
ABSTRACT | FULL TEXT  

Using Genetic Variation to Optimize Nutritional Preemption
Gillies and Krul
J. Nutr. 2007;137:270S-274S.
ABSTRACT | FULL TEXT  

Effect of Folic Acid Supplementation on Risk of Cardiovascular Diseases: A Meta-analysis of Randomized Controlled Trials
Bazzano et al.
JAMA 2006;296:2720-2726.
ABSTRACT | FULL TEXT  

Methylmalonic acid and cognitive function in the Medical Research Council Cognitive Function and Ageing Study
McCracken et al.
Am. J. Clin. Nutr. 2006;84:1406-1411.
ABSTRACT | FULL TEXT  

Elevated serum S-adenosylhomocysteine in cobalamin-deficient elderly and response to treatment
Stabler et al.
Am. J. Clin. Nutr. 2006;84:1422-1429.
ABSTRACT | FULL TEXT  

Apolipoprotein E e4 allele affects risk of hyperhomocysteinemia in the elderly
Ravaglia et al.
Am. J. Clin. Nutr. 2006;84:1473-1480.
ABSTRACT | FULL TEXT  

Methods of detecting atherosclerosis in non-cardiac surgical patients; the role of biochemical markers
Howard-Alpe et al.
Br J Anaesth 2006;97:758-769.
ABSTRACT | FULL TEXT  

Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27 247 adults in 15 prospective studies
The Fibrinogen Studies Collaboration
Int J Epidemiol 2006;35:1570-1578.
ABSTRACT | FULL TEXT  

Bound Homocysteine, Cysteine, and Cysteinylglycine Distribution between Albumin and Globulins
Hortin et al.
Clin. Chem. 2006;52:2258-2264.
ABSTRACT | FULL TEXT  

Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence
Wald et al.
BMJ 2006;333:1114-1117.
FULL TEXT  

Endothelial Nitric Oxide Synthase Gene Polymorphisms and Cardiovascular Disease: A HuGE Review
Casas et al.
Am J Epidemiol 2006;164:921-935.
ABSTRACT | FULL TEXT  

A dual-isotope-labeling method of studying the bioavailability of hexaglutamyl folic acid relative to that of monoglutamyl folic acid in humans by using multiple orally administered low doses.
Melse-Boonstra et al.
Am. J. Clin. Nutr. 2006;84:1128-1133.
ABSTRACT | FULL TEXT  

Relationship of vascular risk to the progression of Alzheimer disease
Regan et al.
Neurology 2006;67:1357-1362.
ABSTRACT | FULL TEXT  

Asymmetrical dimethylarginine regulates endothelial function in methionine-induced but not in chronic homocystinemia in humans: effect of oxidative stress and proinflammatory cytokines.
Antoniades et al.
Am. J. Clin. Nutr. 2006;84:781-788.
ABSTRACT | FULL TEXT  

Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials.
Bleys et al.
Am. J. Clin. Nutr. 2006;84:880-887.
ABSTRACT | FULL TEXT  

Enhanced susceptibility to arterial thrombosis in a murine model of hyperhomocysteinemia
Dayal et al.
Blood 2006;108:2237-2243.
ABSTRACT | FULL TEXT  

Homocysteine and Cardiovascular Disease: Is HDL the Link?
Barter and Rye
Circ. Res. 2006;99:565-566.
FULL TEXT  

Homocysteine Hypothesis for Atherothrombotic Cardiovascular Disease: Not Validated
Kaul et al.
J Am Coll Cardiol 2006;48:914-923.
ABSTRACT | FULL TEXT  

Obese Children and Adolescents: A Risk Group for Low Vitamin B12 Concentration.
Pinhas-Hamiel et al.
Arch Pediatr Adolesc Med 2006;160:933-936.
ABSTRACT | FULL TEXT  

Protective Mechanisms against Homocysteine Toxicity: THE ROLE OF BLEOMYCIN HYDROLASE
Zimny et al.
J. Biol. Chem. 2006;281:22485-22492.
ABSTRACT | FULL TEXT  

Trials that matter: should we routinely measure homocysteine levels and "treat" mild hyperhomocysteinemia?
Rosenberg and Mulrow
ANN INTERN MED 2006;145:226-227.
FULL TEXT  

Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'
Keavney et al.
Int J Epidemiol 2006;35:935-943.
ABSTRACT | FULL TEXT  

Homocysteine, B vitamins, and cardiovascular disease.
de Craen et al.
NEJM 2006;355:205-206.
FULL TEXT  

Impaired Inhibitory Effect of Interleukin-10 on the Balance Between Matrix Metalloproteinase-9 and Its Inhibitor in Mononuclear Cells From Hyperhomocysteinemic Subjects
Holven et al.
Stroke 2006;37:1731-1736.
ABSTRACT | FULL TEXT  

Novel Genomic Loci Influencing Plasma Homocysteine Levels
Kullo et al.
Stroke 2006;37:1703-1709.
ABSTRACT | FULL TEXT  

Vitamins and entacapone in levodopa-induced hyperhomocysteinemia: A randomized controlled study
Postuma et al.
Neurology 2006;66:1941-1943.
ABSTRACT | FULL TEXT  

Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Goldstein et al.
Circulation 2006;113:e873-e923.
ABSTRACT | FULL TEXT  

Dietary patterns are associated with biochemical markers of inflammation and endothelial activation in the Multi-Ethnic Study of Atherosclerosis (MESA)
Nettleton et al.
Am. J. Clin. Nutr. 2006;83:1369-1379.
ABSTRACT | FULL TEXT  

Vitamin and carotenoid status in older women: associations with the frailty syndrome.
Michelon et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2006;61:600-607.
ABSTRACT | FULL TEXT  

The Many Facets of Hyperhomocysteinemia: Studies from the Framingham Cohorts
Selhub
J. Nutr. 2006;136:1726S-1730S.
ABSTRACT | FULL TEXT  

The Hordaland Homocysteine Study: A Community-Based Study of Homocysteine, Its Determinants, and Associations with Disease
Refsum et al.
J. Nutr. 2006;136:1731S-1740S.
ABSTRACT | FULL TEXT  

Primary Prevention of Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline.
Goldstein et al.
Stroke 2006;37:1583-1633.
ABSTRACT | FULL TEXT  

Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations
Vasan
Circulation 2006;113:2335-2362.
FULL TEXT  

Confounding of the Relation between Homocysteine and Peripheral Arterial Disease by Lead, Cadmium, and Renal Function
Guallar et al.
Am J Epidemiol 2006;163:700-708.
ABSTRACT | FULL TEXT  

Homocysteine Trials -- Clear Outcomes for Complex Reasons
Loscalzo
NEJM 2006;354:1629-1632.
FULL TEXT  

Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
Bonaa et al.
NEJM 2006;354:1578-1588.
ABSTRACT | FULL TEXT  

Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
The Heart Outcomes Prevention Evaluation (HOPE) 2
NEJM 2006;354:1567-1577.
ABSTRACT | FULL TEXT  

Relationship Between Homocysteine and Mortality in Chronic Kidney Disease
Menon et al.
Circulation 2006;113:1572-1577.
ABSTRACT | FULL TEXT  

Improvement in Stroke Mortality in Canada and the United States, 1990 to 2002
Yang et al.
Circulation 2006;113:1335-1343.
ABSTRACT | FULL TEXT  

ApoA-I: A Missing Link Between Homocysteine and Lipid Metabolism?
Devlin and Lentz
Circ. Res. 2006;98:431-433.
FULL TEXT  

Interactions among polymorphisms in folate-metabolizing genes and serum total homocysteine concentrations in a healthy elderly population
Devlin et al.
Am. J. Clin. Nutr. 2006;83:708-713.
ABSTRACT | FULL TEXT  

Garlic Reduces Dementia and Heart-Disease Risk
Borek
J. Nutr. 2006;136:810S-812S.
ABSTRACT | FULL TEXT